NOTCH signaling in the skin exerts a pivotal role in the regulation of normal keratinocytes turnover by mediating the balance between proliferation, differentiation, apoptosis and autophagic flux progression. Two skin diseases are characterized by the presence of gene variants that cause an impairment in NOTCH signaling: hidradenitis suppurativa(HS) and Dowling-Degos disease(DDD). To date, both HS and DDD are orphan diseases still lacking of specific treatments. This project aims at improving the current knowledge on the pathogenesis of HS and DDD, by deepening the understandings on the role played by keratinocytes in these pathologies and also by determining why mutations found in the same pathway cause different diseases. This study aimed to obtain in vitro models, derived directly from patients (from hair follicles) and from keratinocytes (HaCaT) cell cultures, for the study of these skin pathologies and also for the testing of novel innovative therapies such as photobiomodulation therapy.
Study Type
OBSERVATIONAL
Enrollment
50
Medical University Innsbruck
Innsbruck, Austria
COMPLETEDUniversité Libre de Bruxelles
Brussels, Belgium
RECRUITINGUniversité Paris Est-Créteil / INSERM U955- Mondor Institute For Biomedical Research (IMRB)
Créteil, France
ACTIVE_NOT_RECRUITINGCentre National de la Recherche Scientifique
Strasbourg, France
ACTIVE_NOT_RECRUITINGDessau Medical Cente
Brandenburg, Germany
NOT_YET_RECRUITINGUniklinik Köln
Cologne, Germany
COMPLETEDFondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinic
Milan, Italy
RECRUITINGAzienda ospedaliero-universitaria pisana
Pisa, Italy
RECRUITINGIstituto Dermopatico dell'Immacolata, IRCCS
Roma, Italy
RECRUITINGPassion people
Roma, Italy
ACTIVE_NOT_RECRUITING...and 5 more locations
Evaluation of the impact of candidate variants in hair follicles epithelial cell biology by generating Knock-Out (KO) keratinocyte cell lines (HaCaT)
Time frame: Through study completion, an average of 36 months
Evaluation of the impact of photobiomodulation (PBM) therapy in hair follicles epithelial cells derived from patients and in HaCaT KO cells,
Time frame: Through study completion, an average of 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.